Manabu Wadamoto

Title: Manabu Wadamoto: Innovator in Pharmaceutical Synthesis

Introduction

Manabu Wadamoto is a distinguished inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical synthesis, holding a total of 2 patents. His work focuses on innovative methods for producing complex chemical compounds that have important applications in medicine.

Latest Patents

Wadamoto's latest patents include a process to make GLP1 RA and intermediates therefor. This invention relates to the synthesis of a specific compound, 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, along with related synthetic intermediate compounds. Another notable patent is a method for preparing aromatic amino acid derivatives. This invention provides efficient methods for producing various optically active aromatic amino acid derivatives by reacting a specific ester compound with an aromatic halide and zinc in the presence of a catalyst.

Career Highlights

Throughout his career, Wadamoto has worked with prominent companies in the pharmaceutical industry, including Chugai Seiyaku Kabushiki Kaisha and Eli Lilly and Company. His experience in these organizations has allowed him to develop and refine his innovative approaches to chemical synthesis.

Collaborations

Wadamoto has collaborated with notable professionals in his field, including Ayman D Allian and Kenneth Derek Berglund. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Manabu Wadamoto is a key figure in the realm of pharmaceutical innovation, with a focus on the synthesis of complex compounds. His contributions through patents and collaborations highlight his commitment to advancing medical science.